Sleep Exacerbations and Facial Twitching: Diagnostic Clues for ADCY5-Related Dyskinesias

Abstract

Background Mutations in the adenylate cyclase 5 (ADCY5) gene are associated with childhood-onset paroxysmal dyskinesia.

Methods We report a new video-documented case of pediatric ADCY5-related dyskinesia with de novo ADCY5 mutation.

Results A boy born to nonconsanguineous parents after an uneventful pregnancy had developmental delay and hypotonia. At the age of 7 months, he presented with paroxysmal jerky–choreic–dystonic involuntary movements in wakefulness involving limbs, trunk, and face, exacerbated by emotional stimuli. These episodes gradually worsened in duration and frequency: at the age of 2.5 years, they occurred up to six times per day, and appeared also during sleep in prolonged bouts; the boy also had basal choreoathetoid–dystonic movements, hyperactivity, paraparetic–ataxic gait, generalized hypotonia with brisk tendon reflexes, drooling, and language delay with intellectual disability. Brain magnetic resonance imaging, electroencephalogram, electromyogram, eye review, metabolic investigations, oligoclonal bands, and autoantibodies were normal. Extensive genetic testing had not let to a diagnosis, until a heterozygous de novo mutation c.1252C > T (p.Arg418Trp) was identified in the ADCY5 gene. Clonazepam had partial effectiveness. The boy walked at the age of 3.5 years. At the age of 5 years, the paroxysmal movement disorder has slightly improved.

Conclusion ADCY5 mutations should be considered among the differential diagnoses of early-onset paroxysmal choreic–athetosic–myoclonic–dystonic movement disorder involving limbs, trunk, and face, in patients with global neurological impairment with hypotonia and developmental delay. Facial dyskinesias and exacerbation by drowsiness/sleep and emotional stimuli are important clues that may allow a timely recognition of the disorder and avoidance of unnecessary diagnostic investigations.

Keywords

adenylate cyclase 5 - ADCY5 - dyskinesia - movement disorder - chorea - dystonia - sleep

Disclosure

The authors report no disclosure.

Publication History

Received: 17 May 2020

Accepted: 09 September 2020

Article published online:
29 December 2020

• References

• 1 Carecchio M, Mencacci NE, Iodice A. et al. ADCY5-related movement disorders: frequency, disease course and phenotypic variability in a cohort of paediatric patients. Parkinsonism Relat Disord 2017; 41: 37-43
• 2 Vijiaratnam N, Bhatia KP, Lang AE, Raskind WH, Espay AJ. ADCY5-related dyskinesia: improving clinical detection of an evolving disorder. Mov Disord Clin Pract (Hoboken) 2019; 6 (07) 512-520
• 3 Chen YZ, Matsushita MM, Robertson P. et al. Autosomal dominant familial dyskinesia and facial myokymia: single exome sequencing identifies a mutation in adenylyl cyclase 5. Arch Neurol 2012; 69 (05) 630-635
• 4 Chang FC, Westenberger A, Dale RC. et al. Phenotypic insights into ADCY5-associated disease. Mov Disord 2016; 31 (07) 1033-1040
• 5 Tunc S, Brüggemann N, Baaske MK. et al. Facial twitches in ADCY5-associated disease - myokymia or myoclonus? An electromyography study. Parkinsonism Relat Disord 2017; 40: 73-75
• 6 Vijiaratnam N, Newby R, Kempster PA. Depression and psychosis in ADCY5-related dyskinesia-part of the phenotypic spectrum?. J Clin Neurosci 2018; 57: 167-168
• 7 Balint B, Antelmi E, Mencacci NE. et al. Oculomotor apraxia and disrupted sleep with nocturnal ballistic bouts in ADCY5-related disease. Parkinsonism Relat Disord 2018; 54: 103-106
• 8 Mencacci NE, Erro R, Wiethoff S. et al. ADCY5 mutations are another cause of benign hereditary chorea. Neurology 2015; 85 (01) 80-88
• 9 Douglas AG, Andreoletti G, Talbot K. et al. ADCY5-related dyskinesia presenting as familial myoclonus-dystonia. Neurogenetics 2017; 18 (02) 111-117
• 10 Kawarai T, Orlacchio A, Kaji R. Lesser motor disability in adulthood: a ten-year follow-up of a dyskinetic patient with ADCY5 mutation. J Neurol Sci 2019; 405: 116383
• 11 Doyle TB, Hayes MP, Chen DH, Raskind WH, Watts VJ. Functional characterization of AC5 gain-of-function variants: impact on the molecular basis of ADCY5-related dyskinesia. Biochem Pharmacol 2019; 163: 169-177
• 12 de Almeida Marcelino AL, Mainka T, Krause P, Poewe W, Ganos C, Kühn AA. Deep brain stimulation reduces (nocturnal) dyskinetic exacerbations in patients with ADCY5 mutation: a case series. J Neurol 2020; 267 (12) 3624-3631